Immtech Pharmaceuticals, Inc.

ACTIVE

93 Prospect Ave, Montclair, New York, United Stateswww.immtechpharma.comHolding11–50 employeesEstablished: 1984-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1984

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Phase 2

40.0%

Phase 3

20.0%

Trial Status Distribution

Completed

60.0%

Terminated

40.0%

Clinical Trials

Trials sponsored by this organization (5)

Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects

Phase 1

Terminated

interventional

Nov 2007100 participants

Prophylactic Antimalarial Activity of DB289 in Volunteers

Phase 1

Completed

interventional

Nov 200619 participants

DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

Phase 3

Terminated

interventional

May 200648 participants

Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Phase 2

Completed

interventional

Feb 2003111 participants

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Phase 2

Completed

interventional

Aug 200130 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations